Semler Scientific (OTCMKTS:SMLR) Stock Price Crosses Above 50 Day Moving Average of $33.20

Semler Scientific, Inc. (OTCMKTS:SMLRGet Rating)’s share price crossed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of $33.20 and traded as high as $37.89. Semler Scientific shares last traded at $36.96, with a volume of 30,086 shares changing hands.

Analysts Set New Price Targets

Separately, B. Riley downgraded shares of Semler Scientific from a “buy” rating to a “neutral” rating and reduced their price objective for the stock from $60.00 to $45.00 in a research report on Wednesday, November 2nd.

Semler Scientific Price Performance

The stock has a market capitalization of $254.24 million, a PE ratio of 21.61 and a beta of 0.62. The business has a 50 day moving average price of $33.28 and a 200 day moving average price of $36.45.

Semler Scientific (OTCMKTS:SMLRGet Rating) last issued its quarterly earnings results on Tuesday, November 1st. The medical equipment provider reported $0.46 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.09. Semler Scientific had a net margin of 23.18% and a return on equity of 27.92%. The business had revenue of $14.05 million for the quarter, compared to the consensus estimate of $15.04 million.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the stock. Bank of America Corp DE raised its position in shares of Semler Scientific by 4,042.1% in the 1st quarter. Bank of America Corp DE now owns 787 shares of the medical equipment provider’s stock valued at $39,000 after purchasing an additional 768 shares during the last quarter. Royal Bank of Canada grew its stake in shares of Semler Scientific by 1,811.2% during the 3rd quarter. Royal Bank of Canada now owns 1,873 shares of the medical equipment provider’s stock worth $70,000 after purchasing an additional 1,775 shares during the period. UBS Group AG grew its stake in shares of Semler Scientific by 893.0% during the 3rd quarter. UBS Group AG now owns 2,274 shares of the medical equipment provider’s stock worth $85,000 after purchasing an additional 2,045 shares during the period. Bank of New York Mellon Corp grew its stake in shares of Semler Scientific by 101.7% during the 1st quarter. Bank of New York Mellon Corp now owns 5,106 shares of the medical equipment provider’s stock worth $253,000 after purchasing an additional 2,574 shares during the period. Finally, Russell Investments Group Ltd. acquired a new stake in shares of Semler Scientific during the 2nd quarter worth approximately $147,000. 58.94% of the stock is currently owned by institutional investors.

About Semler Scientific

(Get Rating)

Semler Scientific, Inc provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.

Read More

Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with MarketBeat.com's FREE daily email newsletter.